Everything is the same, except for the differences

Everything is the same, except for the differences
Topics
Clinical supply forecasting & planning
CTS technology
Pharma/Biotech
Simulations & risk-based optimization
Date
June 28, 2023

“Clinical Supply Forecasting, Simulations or Optimization? Let me tell you what’s what.”

Over the years, the increasing complexity of trial design has made reliable clinical supply chain management both more stressful and a lot more expensive. Thankfully, various solutions were created to help supply teams plan their clinical supplies. They can be split into two main categories: clinical supply forecasting and risk-based optimization.

Clinical supply forecasting

Forecasting tools aim to estimate the average patient demand in clinical trials, so it can be used by the supply team as a foundation for their supply planning. Although these tools work well for predictable studies, working solely with an average ignores the inherent variability and uncertainties of most trials. As a result, it is impossible to estimate the risk associated with any given forecast, and unknowns have to be mitigated through large guesstimated overages, increasing the waste level, supply budget, and generating more stress.

Clinical supply optimization

In contrast, risk-based optimization tools leverage different algorithms to account for those uncertainties and simulate possible trial outcomes using Monte-Carlo simulations. After running thousands of simulations, these tools can predict the average, minimum, and maximum patient demands and incorporate them into any recommendation. As a result, the required overage is provided as an output, and proactive risk control can be performed throughout the trial lifecycle. Forecasting and risk-based optimization solutions are not mutually exclusive. Each approach has its advantages depending on the trial complexity and timing in the trial lifecycle.

Being proactive ensures a smooth clinical trial supply management

Nowadays, a supply optimization solution will be necessary for managing risk with a proactive risk-based approach. This is why being able to transition smoothly and at the appropriate time from forecasting to risk-based optimization is important. Today, N-SIDE offers solutions catered to both small and big pharma companies.
N-SIDE’s software can help with simple and early stage trials but also uses a risk-based optimization solution for complex trials where reducing waste and risk is key.

If you are interested to know more about how forecasting and optimization tools can help you manage your clinical trial supplies in a controlled and sustainable way, ask for a demo of our solutions today!

Author
Marine du Jardin
Marine du Jardin
APAC Regional Manager, N-SIDE
Marine holds a Master’s degree in Business Engineering. Passionate about technology and life sciences, she couldn’t dream of a better place to work than N-SIDE. For the past six years, she has been dedicated to bringing innovation to the clinical trial supply chain through end-to-end optimization. Marine is now responsible for expanding N-SIDE’s global footprint in the APAC market and building strong partnerships in the region.